Deepa Jeyakumar

Title(s)Associate Clinical Professor, Medicine
SchoolSchool of Medicine
Address1001 Health Sciences Road
Irvine CA 92697-3950
Phone(714) 456-5153
vCardDownload vCard

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Narsoplimab for refractory transplantation-associated thrombotic microangiopathy (TA-TMA) in adult patients receiving allogeneic hematopoietic stem cell transplantation (AHSCT). Bone Marrow Transplant. 2025 Apr 22. Chumnumsiriwath P, Vittayawacharin P, Ramos-Perez J, Jeyakumar D, Lee BJ, Doh J, Griffin S, Nguyen M, Hanna RM, Tran MH, Kongtim P, Ciurea SO. PMID: 40263635.
      View in: PubMed   Mentions:    Fields:    
    2. CLO25-058: First-in-Human, Multicenter Phase 1 Study of the Bromodomain 2 Inhibitor ABBV-744 in Relapsed/Refractory Acute Myeloid Leukemia. J Natl Compr Canc Netw. 2025 Mar 28; 23(3.5). Advani A, Odenike O, Jeyakumar D, Mawad R, Frankfurt O, Zha J, Harb JG, Dinh MH, Jonas B, DiNardo CD. PMID: 40154394.
      View in: PubMed   Mentions:    Fields:    
    3. Three-year analysis of adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3. Leukemia. 2025 May; 39(5):1058-1068. Shah BD, Cassaday RD, Park JH, Houot R, Logan AC, Boissel N, Leguay T, Bishop MR, Topp MS, O'Dwyer KM, Tzachanis D, Arellano ML, Lin Y, Baer MR, Schiller GJ, Subklewe M, Abedi M, Minnema MC, Wierda WG, DeAngelo DJ, Stiff P, Jeyakumar D, Mao D, Adhikary S, Zhou L, Hadjivassileva T, Damico Khalid R, Ghobadi A, Oluwole OO. PMID: 40108332; PMCID: PMC12055586.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Budesonide, Added to PTCy-Based Regimen, for Prevention of Acute GI GVHD After Allogeneic Stem Cell Transplantation. Am J Hematol. 2025 Mar; 100(3):383-392. Kongtim P, Chumnumsiriwath P, Vittayawacharin P, Jeyakumar D, Lee BJ, Doh J, Griffin SP, Van Etten RA, Ciurea S. PMID: 39777927.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    5. CPX-351 plus gemtuzumab ozogamicin for relapsed/refractory acute myelogenous leukemia: a University of California Hematologic Malignancies Consortium trial. Leuk Lymphoma. 2025 Apr; 66(4):773-779. Oliai C, Park S, Damon LE, Jonas BA, Jeyakumar D, Wieduwilt MJ, Logan AC, Callas B, Hannigan CA, Gaut DL, Schiller GJ. PMID: 39689718.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCTClinical Trials
    6. Acute Myeloid Leukemia (AML) With T-Cell Differentiation Arising From Chronic Myelomonocytic Leukemia (CMML). Case Rep Hematol. 2024; 2024:5584297. Crymes A, Evans MG, Jeyakumar D, Lou JJ, Zhao X, Rezk SA. PMID: 39734743; PMCID: PMC11671604.
      View in: PubMed   Mentions:
    7. Extending duration of letermovir prophylaxis in haploidentical stem cell transplantation. Haematologica. 2024 Nov 01; 109(11):3806-3810. Vittayawacharin P, Lee BJ, Griffin S, Doh J, Smith J, Nam H, Blodget E, Jeyakumar D, Kongtim P, Ciurea SO. PMID: 38988270; PMCID: PMC11532715.
      View in: PubMed   Mentions:    Fields:    
    8. Intensification of upfront chemotherapy for patients with myeloid blast phase CML: a single center experience. Ann Hematol. 2024 Dec; 103(12):5395-5403. Lee BJ, Griffin SP, Doh J, Ciurea SO, Jeyakumar D, Kongtim P, Naqvi K. PMID: 39438320; PMCID: PMC11695490.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. Outcomes of Surgical Versus Transcatheter Aortic Valve Replacement in Obese Patients: A Systematic Review and Meta-Analysis. Cardiol Rev. 2024 Sep 10. Domondon IAA, Jeyakumar D, Raake M, Halaharvi SP, Zafar F, Contreras Vazquez SA, Abarca YA, Goli SR, Rohra D, Shah F, Sikander M, Al-Tawil M. PMID: 39254505.
      View in: PubMed   Mentions:    Fields:    
    10. Blinatumomab for MRD-Negative Acute Lymphoblastic Leukemia in Adults. N Engl J Med. 2024 Jul 25; 391(4):320-333. Litzow MR, Sun Z, Mattison RJ, Paietta EM, Roberts KG, Zhang Y, Racevskis J, Lazarus HM, Rowe JM, Arber DA, Wieduwilt MJ, Liedtke M, Bergeron J, Wood BL, Zhao Y, Wu G, Chang TC, Zhang W, Pratz KW, Dinner SN, Frey N, Gore SD, Bhatnagar B, Atallah EL, Uy GL, Jeyakumar D, Lin TL, Willman CL, DeAngelo DJ, Patel SB, Elliott MA, Advani AS, Tzachanis D, Vachhani P, Bhave RR, Sharon E, Little RF, Erba HP, Stone RM, Luger SM, Mullighan CG, Tallman MS. PMID: 39047240; PMCID: PMC11334054.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    11. Persistent Impairment in Immune Reconstitution and Worse Survival Outcomes in Allogeneic Stem Cell Transplantation Patients with Early Coronavirus Disease 2019 Infection. Transplant Cell Ther. 2024 Aug; 30(8):816.e1-816.e10. Lee BJ, Vittayawacharin P, Griffin SP, Doh J, Nam HH, Jeyakumar D, Blodget E, Kongtim P, Ciurea SO. PMID: 38710303.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    12. Devimistat plus chemotherapy vs chemotherapy alone for older relapsed or refractory patients with AML: results of the ARMADA trial. Blood Neoplasia. 2024 Jun; 1(2):100009. Pardee TS, Powell BL, Larson RA, Maly J, Keng M, Foster M, Choi EJ, Sill H, Cluzeau T, Jeyakumar D, Frankfurt O, Patel P, Schuster M, Koller E, Costello R, Platzbecker U, Montesinos P, Vives S, Nazha A, Cook R, Vigil-Gonzales C, Chantepie S, Luther S, Cortes J. PMID: 40454396; PMCID: PMC12082102.
      View in: PubMed   Mentions:
    13. Measurable residual disease conversion rate with consolidation chemotherapy in acute myeloid leukemia. Leuk Lymphoma. 2024 Jan; 65(1):69-77. Gaut D, Oliai C, Boiarsky J, Zhang S, Salhotra A, Azenkot T, Kennedy VE, Khanna V, Olmedo Gutierrez K, Shukla N, Moskoff B, Park G, Afkhami M, Patel A, Jeyakumar D, Mannis G, Logan AC, Jonas BA, Schiller G. PMID: 37801340.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. HyperCVAD versus pegaspargase-containing regimens for Hispanic adults with newly diagnosed B-cell acute lymphoblastic leukemia. Eur J Haematol. 2024 Mar; 112(3):392-401. Lee BJ, Griffin SP, Doh J, Chan A, Ciurea SO, Jeyakumar D, Fleischman AG, Naqvi K, Pannunzio NR, O'Brien S, Kongtim P. PMID: 37933194.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    15. Strategies to Mitigate the Drug-Drug Interaction between Nirmatrelvir/Ritonavir and Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplant Recipients on Azole Antifungals: Results of a Case Series. Acta Haematol. 2023 Oct 09; 1-7. Griffin SP, Lee B, Doh J, Paradyse AR, Jeyakumar D, Arter Z, Nam H, Blodget E, Smith J, Valek A, Vittayawacharin P, Kongtim P, Ciurea SO. PMID: 38059378.
      View in: PubMed   Mentions:    Fields:    
    16. Tolerability and Efficacy of the Anticluster of Differentiation 47 Antibody Magrolimab Combined With Azacitidine in Patients With Previously Untreated AML: Phase Ib Results. J Clin Oncol. 2023 11 01; 41(31):4893-4904. Daver NG, Vyas P, Kambhampati S, Al Malki MM, Larson RA, Asch AS, Mannis G, Chai-Ho W, Tanaka TN, Bradley TJ, Jeyakumar D, Wang ES, Sweet K, Kantarjian HM, Garcia-Manero G, Komrokji R, Xing G, Ramsingh G, Renard C, Zeidner JF, Sallman DA. PMID: 37703506; PMCID: PMC10617926.
      View in: PubMed   Mentions: 46     Fields:    Translation:CTClinical Trials
    17. Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trial. Leukemia. 2023 10; 37(10):2017-2026. Sekeres MA, Montesinos P, Novak J, Wang J, Jeyakumar D, Tomlinson B, Mayer J, Jou E, Robak T, Taussig DC, Dombret H, Merchant A, Shaik N, O'Brien T, Roh W, Liu X, Ma W, DiRienzo CG, Chan G, Cortes JE. PMID: 37604981; PMCID: PMC10539167.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    18. Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3. J Immunother Cancer. 2023 08; 11(8). Shah BD, Cassaday RD, Park JH, Houot R, Oluwole OO, Logan AC, Boissel N, Leguay T, Bishop MR, Topp MS, Tzachanis D, O'Dwyer KM, Arellano ML, Lin Y, Baer MR, Schiller GJ, Subklewe M, Abedi M, Minnema MC, Wierda WG, DeAngelo DJ, Stiff PJ, Jeyakumar D, Mao D, Adhikary S, Zhou L, Schuberth PC, Damico Khalid R, Ghobadia A. PMID: 37648261; PMCID: PMC10471850.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    19. A phase 1b study of venetoclax and alvocidib in patients with relapsed/refractory acute myeloid leukemia. Hematol Oncol. 2023 Oct; 41(4):743-752. Jonas BA, Hou JZ, Roboz GJ, Alvares CL, Jeyakumar D, Edwards JR, Erba HP, Kelly RJ, Röllig C, Fiedler W, Brackman D, Siddani SR, Chyla B, Hilger-Rolfe J, Watts JM. PMID: 37086447; PMCID: PMC10757832.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCTClinical Trials
    20. Impact of triple intrathecal prophylaxis in acute lymphoblastic leukemia adults receiving HyperCVAD: A COVID-19 practice change. Eur J Haematol. 2023 Jul; 111(1):154-160. Lee BJ, Kongtim P, Doh J, Griffin SP, Chan A, O'Brien S, Ciurea SO, Jeyakumar D. PMID: 37086155.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    21. Dasatinib/prednisone induction followed by blinatumomab/dasatinib in Ph+ acute lymphoblastic leukemia. Blood Adv. 2023 04 11; 7(7):1279-1285. Advani AS, Moseley A, O'Dwyer KM, Wood BL, Park J, Wieduwilt M, Jeyakumar D, Yaghmour G, Atallah EL, Gerds AT, O'Brien SM, Liesveld JL, Othus M, Litzow M, Stone RM, Sharon E, Erba HP. PMID: 36322825; PMCID: PMC10090098.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    22. Magrolimab in Combination With Azacitidine in Patients With Higher-Risk Myelodysplastic Syndromes: Final Results of a Phase Ib Study. J Clin Oncol. 2023 05 20; 41(15):2815-2826. Sallman DA, Al Malki MM, Asch AS, Wang ES, Jurcic JG, Bradley TJ, Flinn IW, Pollyea DA, Kambhampati S, Tanaka TN, Zeidner JF, Garcia-Manero G, Jeyakumar D, Komrokji R, Lancet J, Kantarjian HM, Gu L, Zhang Y, Tan A, Chao M, O'Hear C, Ramsingh G, Lal I, Vyas P, Daver NG. PMID: 36888930; PMCID: PMC10414740.
      View in: PubMed   Mentions: 47     Fields:    Translation:CTClinical Trials
    23. Once-Daily Foscarnet Is Effective for Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell Transplantation. Transplant Cell Ther. 2023 06; 29(6):397.e1-397.e6. Vittayawacharin P, E'Leimat G, Lee BJ, Griffin S, Doh J, Nam H, Blodget E, Jeyakumar D, Kongtim P, Ciurea SO. PMID: 36878429.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    24. Timing of intrathecal chemotherapy and blinatumomab impacts neurotoxicity in acute lymphoblastic leukemia. Am J Hematol. 2023 05; 98(5):E113-E115. Lee BJ, Griffin SP, Doh J, Kongtim P, Chan A, O'Brien S, Jeyakumar D, Ciurea SO. PMID: 36794446.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    25. Two-year follow-up of KTE-X19 in patients with relapsed or refractory adult B-cell acute lymphoblastic leukemia in ZUMA-3 and its contextualization with SCHOLAR-3, an external historical control study. J Hematol Oncol. 2022 12 10; 15(1):170. Shah BD, Ghobadi A, Oluwole OO, Logan AC, Boissel N, Cassaday RD, Leguay T, Bishop MR, Topp MS, Tzachanis D, O'Dwyer KM, Arellano ML, Lin Y, Baer MR, Schiller GJ, Park JH, Subklewe M, Abedi M, Minnema MC, Wierda WG, DeAngelo DJ, Stiff P, Jeyakumar D, Dong J, Adhikary S, Zhou L, Schuberth PC, Faghmous I, Masouleh BK, Houot R. PMID: 36494725; PMCID: PMC9734710.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    26. CD19-directed immunotherapy use in KMT2A-rearranged acute leukemia: A case report and literature review of increased lymphoid to myeloid lineage switch. Am J Hematol. 2022 12; 97(12):E439-E443. Lee BJ, Griffin SP, Doh J, Chan A, O'Brien S, Jeyakumar D, Ciurea SO, Becker PS, Kongtim P. PMID: 36057135.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    27. Increased incidence of Pegaspargase-induced hypertriglyceridemia and associated pancreatitis observed in the Hispanic adult patient population. Leuk Lymphoma. 2022 12; 63(12):2992-2995. Lee BJ, Doh J, Chan A, Jeyakumar D, O'Brien S. PMID: 35834729.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    28. KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study. Lancet. 2021 08 07; 398(10299):491-502. Shah BD, Ghobadi A, Oluwole OO, Logan AC, Boissel N, Cassaday RD, Leguay T, Bishop MR, Topp MS, Tzachanis D, O'Dwyer KM, Arellano ML, Lin Y, Baer MR, Schiller GJ, Park JH, Subklewe M, Abedi M, Minnema MC, Wierda WG, DeAngelo DJ, Stiff P, Jeyakumar D, Feng C, Dong J, Shen T, Milletti F, Rossi JM, Vezan R, Masouleh BK, Houot R. PMID: 34097852; PMCID: PMC11613962.
      View in: PubMed   Mentions: 289     Fields:    Translation:HumansCTClinical Trials
    29. Minimal Residual Disease in Acute Myeloid Leukemia. JAMA Oncol. 2020 12 01; 6(12):1899-1900. Jeyakumar D, O'Brien S. PMID: 33030511.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    30. Prolymphocytic transformation of lymphoplasmacytic lymphoma: an extremely unusual event. Hum Pathol. 2019 08; 90:106-110. Zhang K, Farrell D, Jeyakumar D, O'Brien S, Zhao X, Rezk SA. PMID: 30342054.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    31. A Patient with Supraclavicular Lymphadenopathy and Anterior Mediastinal Mass Presenting as a Rare Case of Composite Lymphoma: A Case Report and Literature Review. Case Rep Oncol. 2016 Sep-Dec; 9(3):854-860. Raufi A, Jerkins J, Lyou Y, Jeyakumar D. PMID: 28203178; PMCID: PMC5260532.
      View in: PubMed   Mentions: 2  
    32. Biodegradation of polycyclic aromatic hydrocarbons by an acidophilic Stenotrophomonas maltophilia strain AJH1 isolated from a mineral mining site in Saudi Arabia. Extremophiles. 2017 Jan; 21(1):163-174. Arulazhagan P, Al-Shekri K, Huda Q, Godon JJ, Basahi JM, Jeyakumar D. PMID: 27848015.
      View in: PubMed   Mentions: 18     Fields:    Translation:CellsPHPublic Health
    33. The Next Generation of Targeted Molecules for the Treatment of Chronic Lymphocytic Leukemia. Oncology (Williston Park). 2016 11 15; 30(11):1008-15. Jeyakumar D, O'Brien S. PMID: 27854102.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    34. B cell receptor inhibition as a target for CLL therapy. Best Pract Res Clin Haematol. 2016 03; 29(1):2-14. Jeyakumar D, O'Brien S. PMID: 27742069.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    35. Synergistic effects of pretreatment and blending on fungi mediated biodegradation of polypropylenes. Bioresour Technol. 2013 Nov; 148:78-85. Jeyakumar D, Chirsteen J, Doble M. PMID: 24045194.
      View in: PubMed   Mentions: 26     Fields:    Translation:AnimalsPHPublic Health
    36. An ab initio molecular orbital study of the reduction of carbonyls by alkylaluminum complexes. J Mol Graph Model. 2005 Dec; 24(3):195-202. Bundens JW, Seida PR, Jeyakumar D, Francl MM. PMID: 16126421.
      View in: PubMed   Mentions: 1     Fields:    Translation:Cells
    37. Long HIV type 1 reverse transcripts can accumulate stably within resting CD4+ T cells while short ones are degraded. AIDS Res Hum Retroviruses. 2004 Mar; 20(3):285-95. Swiggard WJ, O'Doherty U, McGain D, Jeyakumar D, Malim MH. PMID: 15117452.
      View in: PubMed   Mentions: 28     Fields:    Translation:HumansCells
    38. A sensitive, quantitative assay for human immunodeficiency virus type 1 integration. J Virol. 2002 Nov; 76(21):10942-50. O'Doherty U, Swiggard WJ, Jeyakumar D, McGain D, Malim MH. PMID: 12368337; PMCID: PMC136638.
      View in: PubMed   Mentions: 119     Fields:    Translation:HumansCells
    Deepa's Networks
    Concepts (144)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (26)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCI Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version UCSF-v3.1.0-15-g9ae42700 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California